Newsletter | July 13, 2023

07.13.23 -- Humira Biosimilars Take The U.S. Market By Storm
 
Featured Editorial
The Global Market For Generic Sterile Injectables To Double In Value By 2032
 
By Aditi Shivarkar, insightSLICE

According to new analysis at insightSLICE, the global generic sterile injectable market size was estimated to be $79.95 billion in 2022 and is expected to grow to reach $159 billion by 2032. What are the key factors and trends driving this growth? This author shares the key data-led insights.
5 Hot-Button Issues In Parenteral Packaging
 
By Fran L. DeGrazio, Strategic Parenteral Solutions LLS

Five key issues related to parenteral drug packaging came to the forefront of the PDA Parenteral Packaging Conference held in Venice, Italy, in April.
Industry Insights
Key Considerations For Selecting Fill/Finish Manufacturing Technologies
White Paper | By Eleftherios Hristofas, West Pharmaceutical Services, Inc.

Obtaining information and proactively mapping out your fill/finish strategy early can de-risk an investment in equipment or processes, ensuring you meet your long-term needs.
Taking Charge Of Your Stability Program
White Paper | By P. Hamill, A. Glekas, and G. Pirozzi, MilliporeSigma Biosafety Testing Services

Conducting stability studies is a critical aspect of the drug development process. Learn how consolidating stability testing with a single partner offers improved efficiency, reduced risk, and more.
Wearable Injectors: An Alternative To Traditional Intravenous Administration
Infographic | BD Medical - Pharmaceutical Systems

See a quick visual summary of findings from an early feasibility clinical study featuring a 2-5 mL wearable injector with a viscous placebo.
News Headlines
Solutions
Can You Run Crude Samples Using An SPR Instrument?
Cytiva
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.